您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Ginsenoside Rc
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Ginsenoside Rc
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Ginsenoside Rc图片
CAS NO:11021-14-0
包装与价格:
包装价格(元)
10 mM * 1 mL in DMSO电议
5mg电议
10mg电议
50mg电议
100mg电议

产品名称
人参皂苷 Rc
Panaxoside Rc
产品介绍
Ginsenoside Rc 是主要的人参皂甙之一,Ginsenoside Rc 增强 GABA 受体 A (GABAA) 介导的离子通道 (IGABA)电流。 Ginsenoside Rc 还抑制TNF-αIL-1β表达。
生物活性

Ginsenoside Rc, one of major Ginsenosides fromPanax ginseng, enhancesGABA receptorA(GABAA)-mediated ion channel currents (IGABA). Ginsenoside Rc inhibits the expression ofTNF-αandIL-1β.

IC50& Target[2]

IL-1

 

IL-1β

 

体外研究
(In Vitro)

Ginsenoside Rc, one of major Ginsenosides from Panax ginseng, enhances γ-aminobutyric acid (GABA) receptorA(GABAA)-mediated ion channel currents. Ginsenoside Rc enhances GABA-mediated ion currents in oocytes expressing the GABAAreceptor[1]. Ginsenoside Rc significantly inhibits the expression of macrophage-derived cytokines, such as TNF-α and IL-1β. Ginsenoside Rc also markedly suppresses the activation of TANK-binding kinase 1/IκB kinase ε/interferon regulatory factor-3 and p38/ATF-2 signaling in activated RAW264.7 macrophages, human synovial cells, and HEK293 cells. Ginsenoside Rc exerts its anti-inflammatory actions by suppressing TANK-binding kinase 1/IκB kinase ε/interferon regulatory factor-3 and p38/ATF-2 signaling. Ginsenoside Rc suppresses the nuclear translocation of phospho-ATF-2 and phospho-FRA-1, whereas the translocation of p65 at its peak time points (30 and 60 min) is not decreased by Ginsenoside Rc treatment. Ginsenoside Rc regulates the expression of the proinflammatory cytokine TNF-α, which is produced by macrophages, by suppressing AP-1 activation[2].

分子量

1079.27

性状

Solid

Formula

C53H90O22

CAS 号

11021-14-0

中文名称

人参皂苷 Rc

结构分类
  • Terpenoids
  • Triterpenes
来源
  • Plants
  • Araliaceae
  • Panax ginsengC. A. Meyer
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder-20°C3 years
4°C2 years
In solvent-80°C6 months
-20°C1 month
溶解性数据
In Vitro: 

DMSO : 100 mg/mL(92.66 mM;Need ultrasonic)

H2O : 50 mg/mL(46.33 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM0.9266 mL4.6328 mL9.2655 mL
5 mM0.1853 mL0.9266 mL1.8531 mL
10 mM0.0927 mL0.4633 mL0.9266 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 33.33 mg/mL (30.88 mM); Clear solution; Need ultrasonic

*以上所有助溶剂都可在本网站选购。